European Wax Center Files Definitive Proxy for $5.80/Share Go-Private Merger
summarizeSummary
European Wax Center filed a definitive proxy statement for its go-private merger, confirming the $5.80 per share cash acquisition by General Atlantic affiliates and scheduling a shareholder vote for May 7, 2026.
check_boxKey Events
-
Definitive Merger Agreement Filed
European Wax Center filed a definitive proxy statement (DEFM14A) for its go-private merger, detailing the terms of its acquisition by affiliates of General Atlantic.
-
Acquisition Price Confirmed
Shareholders will receive $5.80 per share in cash, which represented a 48% premium over the 30-day volume weighted average share price prior to the merger announcement on February 9, 2026.
-
Shareholder Vote Scheduled
A special meeting for stockholders to vote on the merger is scheduled for May 7, 2026. Approval requires a majority vote from disinterested stockholders.
-
Financing Details Disclosed
The merger is financed by $74 million in debt and $110 million in equity from General Atlantic affiliates, supplemented by the company's cash on hand, totaling approximately $219.2 million.
auto_awesomeAnalysis
This DEFM14A filing is a critical procedural step in European Wax Center's go-private merger. It provides comprehensive details of the previously announced acquisition by General Atlantic affiliates for $5.80 per share in cash. While the merger price was disclosed in the preliminary proxy, this definitive statement formalizes the terms, includes a fairness opinion from Moelis & Company LLC, and sets the shareholder meeting for May 7, 2026. The transaction, valued at approximately $219.2 million, represents a substantial portion of the company's market capitalization and, if approved, will result in the company's delisting from Nasdaq. The requirement for a majority vote from disinterested stockholders adds a layer of scrutiny to the approval process.
At the time of this filing, EWCZ was trading at $5.81 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $255.7M. The 52-week trading range was $2.95 to $6.52. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.